News
News
- Novan Announces Receipt of Written Minutes from Type C Meeting with FDA Regarding Development of SB206
04/30/2020 / 22:05 - GlobeNewswire - Novan Announces Comprehensive Evaluation of Strategic and Financial Alternatives
04/20/2020 / 22:05 - GlobeNewswire - Novan Receives Verbal Guidance from FDA for SB206 and Announces Sato Program Advancement
04/03/2020 / 14:15 - GlobeNewswire - Novan Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market
03/26/2020 / 21:05 - GlobeNewswire - Novan Announces $8.0 Million Registered Direct Offering Priced At-the-Market
03/24/2020 / 13:10 - GlobeNewswire - Novan Announces Data from B-SIMPLE Week 24 Safety Evaluation and COVID-19 Business Updates
03/23/2020 / 13:15 - GlobeNewswire - Novan Announces Closing of $5.95 Million Public Offering, including Partial Exercise of the Underwriter’s Option to Purchase Additional Securities
03/03/2020 / 22:05 - GlobeNewswire - Novan Announces Pricing of $5.5 Million Public Offering
02/28/2020 / 05:20 - GlobeNewswire - Novan Announces Proposed Public Offering
02/27/2020 / 22:01 - GlobeNewswire - Novan Receives Phase 2 NIH Federal Grant of Approximately $1.0 Million
02/20/2020 / 14:15 - GlobeNewswire
Real-time